Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Leukemia

Free Subscription 06.06.2022 2 Am J Hematol 2 Ann Hematol 1 Blood 1 Bone Marrow Transplant 4 Br J Haematol 1 Eur J Haematol 1 Genes Chromosomes Cancer 1 Int J Hematol 1 J Pediatr Hematol Oncol 6 Leuk Lymphoma 4 Leuk Res 5 Leukemia 1 Semin Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. PAUL S, Kantarjian H, Sasaki K, Marx K, et al
   Intrathecal Prophylaxis with 12 Versus 8 Administrations Reduces the Incidence of Central Nervous System Relapse in Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.
   Am J Hematol. 2022 May 28. doi: 10.1002/ajh.26622.
   PubMed        
   
   
2. CHERNG HJ, Khwaja R, Kanagal-Shamanna R, Tang G, et al
   TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis.
   Am J Hematol. 2022 May 14. doi: 10.1002/ajh.26595.
   PubMed         Abstract available
   
   

   
   Ann Hematol

3. LEUNG WY, Cheuk DK, Cheng FW, Leung AW, et al
   Outcome prediction of chronic myeloid leukemia (CML) in children.
   Ann Hematol. 2022 Jun 1. pii: 10.1007/s00277-022-04852.
   PubMed         Abstract available
   
   
4. OCHS MA, Marini BL, Perissinotti AJ, Foucar CE, et al
   Oncology stewardship in acute myeloid leukemia.
   Ann Hematol. 2022 May 26. pii: 10.1007/s00277-022-04872.
   PubMed         Abstract available
   
   

   
   Blood

5. SONG H, Liu Y, Tan Y, Zhang Y, et al
   Recurrent non-coding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia.
   Blood. 2022 Jun 2. pii: 485457. doi: 10.1182/blood.2021014945.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

6. GUIJARRO F, Bataller A, Diaz-Beya M, Garrido A, et al
   Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan.
   Bone Marrow Transplant. 2022 May 28. pii: 10.1038/s41409-022-01703.
   PubMed         Abstract available
   
   

   
   Br J Haematol

7. WANG QQ, Wang HF, Zhao JZ, Naranmandura H, et al
   Venetoclax for arsenic-resistant acute promyelocytic leukaemia.
   Br J Haematol. 2022;197:e58-e60.
   PubMed        
   
   
8. MOIA R, Gaidano G
   Updated revision of the British Society of Haematology guidelines for chronic lymphocytic leukaemia.
   Br J Haematol. 2022;197:513-514.
   PubMed        
   
   
9. WALEWSKA R, Parry-Jones N, Eyre TA, Follows G, et al
   Guideline for the treatment of chronic lymphocytic leukaemia.
   Br J Haematol. 2022;197:544-557.
   PubMed        
   
   
10. BRIVIO E, Cossio A, Borra D, Silvestri D, et al
    Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort.
    Br J Haematol. 2022;197:602-608.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

11. KOLONEN A, Sinisalo M, Huhtala H, Rimpilainen J, et al
    Efficacy of conventional-dose cytarabine, idarubicin and thioguanine (IAT) versus intermediate-dose cytarabine and idarubicin (IdAraC-Ida) in the induction treatment of AML: long-term results of the prospective randomized nationwide AML-2003 study by
    Eur J Haematol. 2022 May 30. doi: 10.1111/ejh.13805.
    PubMed         Abstract available
    
    

    
    Genes Chromosomes Cancer

12. GAGNON MF, Berg HE, Meyer RG, Sukov WR, et al
    Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: a retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studies.
    Genes Chromosomes Cancer. 2022 May 31. doi: 10.1002/gcc.23070.
    PubMed         Abstract available
    
    

    
    Int J Hematol

13. NAKAYAMA H, Ogawa C, Sekimizu M, Fujisaki H, et al
    A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1).
    Int J Hematol. 2022 May 30. pii: 10.1007/s12185-022-03388.
    PubMed         Abstract available
    
    

    
    J Pediatr Hematol Oncol

14. WANG J, Li X, Liu C, Wang S, et al
    Effect of BCG HSP70 Gene Transfection on Dendritic Cells Derived From Bone Marrow in Children With Acute Leukemia.
    J Pediatr Hematol Oncol. 2022 May 11. pii: 00043426-990000000-00036.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

15. BALL S, Komrokji RS, Sallman DA
    Prognostic scoring systems and risk stratification in myelodysplastic syndrome: focus on integration of molecular profile.
    Leuk Lymphoma. 2022;63:1281-1291.
    PubMed         Abstract available
    
    
16. SHARPLIN KM, Marks DI
    The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL).
    Leuk Lymphoma. 2022;63:1292-1301.
    PubMed         Abstract available
    
    
17. TAHIR F, Sy J, Reddel S, Trotman J, et al
    Progressive multifocal leukoencephalopathy post ibrutinib therapy in relapsed chronic lymphocytic leukaemia.
    Leuk Lymphoma. 2022;63:1464-1468.
    PubMed         Abstract available
    
    
18. MATUTES E, Polliack A
    Is ibrutinib the gold standard for therapy - naive elderly patients with CLL?
    Leuk Lymphoma. 2022;63:1265-1266.
    PubMed        
    
    
19. GADAUD N, Leroy H, Berard E, Tavitian S, et al
    Azacitidine, intensive chemotherapy or best supportive care in relapsed or refractory acute myeloid leukemia, a DATAML registry study.
    Leuk Lymphoma. 2022;63:1398-1406.
    PubMed         Abstract available
    
    
20. XU J, Hao Z, Chen X, Hong M, et al
    The characteristics and clinical prognosis analysis of ASXL1 mutations in Chinese adult patients with primary cytogenetically normal acute myeloid leukemia by next-generation sequencing.
    Leuk Lymphoma. 2022 Jun 2:1-9. doi: 10.1080/10428194.2022.2081323.
    PubMed         Abstract available
    
    

    
    Leuk Res

21. STEIDL C, Aroldi A, Mologni L, Crespiatico I, et al
    Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience.
    Leuk Res. 2022;118:106861.
    PubMed         Abstract available
    
    
22. GOSWAMI S, Chiang CL, Zapolnik K, Nunes J, et al
    ROR1 targeted immunoliposomal delivery of OSU-2S shows selective cytotoxicity in t(1;19)(q23;p13) translocated B-cell acute lymphoblastic leukemia.
    Leuk Res. 2022;118:106872.
    PubMed        
    
    
23. TASHAKORI M, Wang W, Kadia TM, Daver NG, et al
    Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy.
    Leuk Res. 2022;118:106860.
    PubMed         Abstract available
    
    
24. HASHIMOTO H, Gungor D, Krickeberg N, Schmitt J, et al
    TH1 cytokines induce senescence in AML.
    Leuk Res. 2022;117:106842.
    PubMed         Abstract available
    
    

    
    Leukemia

25. ZHANG XS, Gale RP, Li ZY, Zhang MY, et al
    Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy.
    Leukemia. 2022 Jun 1. pii: 10.1038/s41375-022-01616.
    PubMed         Abstract available
    
    
26. BRUMMENDORF TH, Cortes JE, Milojkovic D, Gambacorti-Passerini C, et al
    Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
    Leukemia. 2022 May 28. pii: 10.1038/s41375-022-01589.
    PubMed         Abstract available
    
    
27. MOSHIRI H, Cabrera Riofrio DA, Lim YJ, Lauhasurayotin S, et al
    Germline PTPN13 mutations in patients with bone marrow failure and acute lymphoblastic leukemia.
    Leukemia. 2022 May 28. pii: 10.1038/s41375-022-01610.
    PubMed        
    
    
28. MAN CH, Zeng X, Lam W, Ng TCC, et al
    Regulation of proton partitioning in kinase-activating acute myeloid leukemia and its therapeutic implication.
    Leukemia. 2022 May 27. pii: 10.1038/s41375-022-01606.
    PubMed         Abstract available
    
    
29. VINADO AC, Calvo IA, Cenzano I, Olaverri D, et al
    The bone marrow niche regulates redox and energy balance in MLL::AF9 leukemia stem cells.
    Leukemia. 2022 May 26. pii: 10.1038/s41375-022-01601.
    PubMed         Abstract available
    
    

    
    Semin Oncol

30. DESTEFANO CB, Gibson SJ, Sperling AS, Richardson PG, et al
    The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma.
    Semin Oncol. 2022;49:19-26.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: